Vanderbilt Ingram Cancer Center

The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has awarded a three-year grant to support research led by Houra Merrikh, PhD, professor of Biochemistry, and Ben Ho Park, MD, PhD, the Benjamin F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, to create an anti-evolution drug to reduce the capacity of cancer cells to develop resistance. Read More

The Vanderbilt-Ingram Cancer Center announced a funding opportunity to support impactful cancer-related projects at any stage of research from any stage faculty member. This award aims to provide funding to support paradigm-shifting, practice-changing, or policy-creating research. Read More

Vanderbilt's Andreana Holowatyj, PhD, MSCI, has received the National Cancer Institute’s Method to Extend Research in Time Award to support her ongoing investigation into how early-onset colorectal cancer and its treatments impact reproductive health. Read More

A Vanderbilt study that delved into genetic predisposition for early-onset colorectal cancer by race and ethnicity has identified differing germline risk variants. Read More

An international collaboration led by biochemist David Cortez reached revelatory conclusions in exploration of how cells tolerate DNA damage and genome instability. Est. reading time: 2 mins. Read More

For her scholarship that has led to the development of new diagnostic and therapeutic approaches for thyroid cancer, Dr. Nancy Carrasco has been honored with a 2023 SEC Faculty Achievement Award. Read More

The overall goal of the Vanderbilt-Ingram Cancer Center SPORE in Breast Cancer is to conduct collaborative, multidisciplinary and mechanism-based translational research that will have the highest possible impact for women and men with or at risk for breast cancer. Read More

The overall goal of the Vanderbilt-Ingram Cancer Center SPORE in Breast Cancer is to conduct collaborative, multidisciplinary and mechanism-based translational research that will have the highest possible impact for women and men with or at risk for breast cancer. Read More

The Vanderbilt-Ingram Cancer Center and The Richard S. Reynolds Foundation are pleased to announce a new funding opportunity for studies proposing translational innovations. Read More

Researchers from from Vanderbilt-Ingram Cancer Center have identified the mechanism for the deadly heart inflammation myocarditis. Read More

Vanderbilt reseach shows that resources for lung cancer screening programs increased the number of veterans screened. Read More

A Vanderbilt study suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers. Read More

Applications are requested for the Stephen Voland Neuro-oncology Research Award for 2022–23. Read More

Combining genetic testing with information from electronic health records revealed undiagnosed heart rhythm disorders and new conditions associated with inherited cancer gene mutations. Read More

A study by Vanderbilt and New York City researchers found that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease Read More

The Vanderbilt-Ingram Cancer Center's 23rd annual Scientific Retreat will be held on May 2 in the Student Life Center with national and international experts presenting on "Advances in Lung Cancer Research." Registration is open now. Read More

Melanoma is the fifth most-common type of cancer in the U.S., and according to the American Cancer Society, about half of patients with malignant melanoma have mutations of the BRAF gene. Identification of potential tumor biomarkers such as SOX10 can help physicians better predict outcomes for their patients.  Read More

Higher dietary intake of antioxidant compounds found in fruits, vegetables, teas and spices was associated with lower risk of colorectal cancer, and intake was lower among Black participants, potentially contributing to colorectal cancer health disparities. Read More

The Vanderbilt-Ingram Cancer Center and The Richard S. Reynolds Foundation are pleased to announce a new funding opportunity for studies proposing translational innovations. Read More

The Vanderbilt-Ingram Cancer Center SPORE in Breast Cancer announces a Developmental Research Program pilot funding opportunity focused on catalyzing innovative and transformative breast cancer-related projects that promote discoveries in basic and translational research focused on metastatic disease. Read More